|
|
|
CfPA-The Center for Professional Advancement, 90 Minute Accredited Online Training
April 23, 2015 at 11:00 a.m.–12:30 p.m. (ET)
Who Should Attend? This training will be beneficial to professionals in the Pharmaceutical, Cell Therapy, Diagnostics, Biologics, Biotechnology and Medical Device Industries. The employees who will benefit most include personnel and management within: • Quality Control Analyst • Regulatory Affairs • Manufacturing Associates • Shipping and Receiving • Facility and Utility • Materials Handling • Quality Assurance Analyst • Supplier Quality • Vendors and Suppliers of Pharmaceutical Water Systems and Peripherals
Site Directors, Operations Director and Senior Management will also find this training valuable. Course Description
|
|
|
|
|
|
Organized by:
|
|
CfPA-The Center for Professional Advancement |
|
Invited Speakers:
|
|
Charity Ogunsanya (CEO/Founder), Pharmabiodevice Consulting LLC |
Charity Ogunsanya has more than 24 years of extensive experience within the Biologics, Pharmaceuticals, Radiopharmaceuticals, Biotechnology, Cell Therapy, Diagnostics, Drug and Medical Device Industries and has been the Microbiology, Sterility Assurance, Contamination Control, Aseptic processing, Quality Control subject matter expert for multiple fortune 100 companies. She has a Bachelor of Science degree in Microbiology from the University of Benin-Nigeria and is currently in the Advanced Academic Master’s Biotechnology Program at the Johns Hopkins University with concentration in Biodefense. She is the CEO/Founder of Pharmabiodevice Consulting LLC. The consultancy provides Quality and Compliance consultancy/support to Biologics, Pharmaceuticals, Cell Therapy, Radiopharmaceuticals, Biotechnology and Medical Device Industries.
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
E-mail:
|
|
sberg@cfpa.com
|
|
|
|
|
|
|
|
This 90-minute accredited training will guide a drug product manufacturer with effectively designing, validating and maintaining a new or existing water system. The appropriate design planning considerations, validation, types of routine tests, testing frequencies, water system maintenance and how to set an acceptable alert and action levels will be reviewed. Water test result/data management and trending which will be a guide to a steady state of control of the different water systems will be presented. This will benefit the manufacturers by helping to avoid future costly pharmaceutical water systems failure, investigations or inability to validate or achieve passing test results from a new or existing water systems emanating from design-related issues.